Marizyme Stock Price Prediction

MRZM Stock  USD 0.04  0.01  20.00%   
As of now the value of rsi of Marizyme's share price is below 20 . This indicates that the otc stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Oversold Vs Overbought

19

 
Oversold
 
Overbought
Marizyme stock price prediction is an act of determining the future value of Marizyme shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Marizyme's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Marizyme and does not consider all of the tangible or intangible factors available from Marizyme's fundamental data. We analyze noise-free headlines and recent hype associated with Marizyme, which may create opportunities for some arbitrage if properly timed.
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Marizyme based on different types of headlines from major news networks to social media. Using Marizyme hype-based prediction, you can estimate the value of Marizyme from the perspective of Marizyme response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Marizyme. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Marizyme to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Marizyme because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Marizyme after-hype prediction price

    
  USD 0.04  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Marizyme Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
0.000.0421.31
Details
Naive
Forecast
LowNextHigh
00.0621.33
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.040.050.06
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Marizyme. Your research has to be compared to or analyzed against Marizyme's peers to derive any actionable benefits. When done correctly, Marizyme's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Marizyme.

Marizyme After-Hype Price Prediction Density Analysis

As far as predicting the price of Marizyme at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Marizyme or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Marizyme, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Marizyme Estimiated After-Hype Price Volatility

In the context of predicting Marizyme's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Marizyme's historical news coverage. Marizyme's after-hype downside and upside margins for the prediction period are 0.00 and 21.31, respectively. We have considered Marizyme's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.04
0.04
After-hype Price
21.31
Upside
Marizyme is out of control at this time. Analysis and calculation of next after-hype price of Marizyme is based on 3 months time horizon.

Marizyme OTC Stock Price Prediction Analysis

Have you ever been surprised when a price of a OTC Stock such as Marizyme is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Marizyme backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Marizyme, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  2.26 
21.27
 0.00  
  0.03 
0 Events / Month
6 Events / Month
Uncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.04
0.04
0.00 
0.00  
Notes

Marizyme Hype Timeline

Marizyme is now traded for 0.04. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.03. Marizyme is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 2.26%. %. The volatility of related hype on Marizyme is about 147900.91%, with the expected price after the next announcement by competition of 0.01. The company has price-to-book ratio of 0.37. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Marizyme recorded a loss per share of 0.39. The entity last dividend was issued on the 27th of July 2018. The firm had 1:29 split on the 27th of July 2018. Given the investment horizon of 90 days the next forecasted press release will be uncertain.
Check out Marizyme Basic Forecasting Models to cross-verify your projections.

Marizyme Related Hype Analysis

Having access to credible news sources related to Marizyme's direct competition is more important than ever and may enhance your ability to predict Marizyme's future price movements. Getting to know how Marizyme's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Marizyme may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
GLSHGelesis Holdings 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
NRXPWNRx Pharmaceuticals 0.02 3 per month 14.39  0.06  27.27 (28.67) 100.20 
RCARRenovaCare 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
AVTEAerovate Therapeutics(0.02)3 per month 2.13  0.13  5.58 (3.86) 19.11 
CDAKQCodiak BioSciences 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
SCPSScopus Biopharma 0.00 0 per month 16.27  0.01  33.33 (24.62) 94.02 
MGTAMagenta Therapeutics(0.02)2 per month 3.40 (0) 5.88 (4.29) 16.99 
ALNAQAllena Pharmaceuticals 0.00 0 per month 17.66  0.05  45.45 (22.22) 150.00 
AKTXAkari Therapeutics PLC(0.05)6 per month 0.00 (0.28) 4.84 (12.59) 47.27 
ARMPArmata Pharmaceuticals(0.1)3 per month 0.00 (0.04) 6.19 (7.05) 33.83 
ANEBAnebulo Pharmaceuticals 0.03 5 per month 0.00 (0.04) 8.61 (11.48) 76.00 
PCSAProcessa Pharmaceuticals(0.01)4 per month 0.00 (0.16) 6.20 (5.34) 20.99 
IKTInhibikase Therapeutics 0.01 8 per month 4.82  0.13  13.45 (9.09) 37.40 
SIOXSio Gene Therapies 0.00 5 per month 0.00 (0.12) 2.33 (2.38) 11.21 
KLDOKaleido Biosciences 0.00 0 per month 0.00  0.13  50.00  0.00  4,849 
TPSTTempest Therapeutics(0.09)4 per month 0.00 (0.13) 6.38 (8.53) 29.55 

Marizyme Additional Predictive Modules

Most predictive techniques to examine Marizyme price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Marizyme using various technical indicators. When you analyze Marizyme charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Marizyme Predictive Indicators

The successful prediction of Marizyme stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Marizyme, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Marizyme based on analysis of Marizyme hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Marizyme's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Marizyme's related companies.

Story Coverage note for Marizyme

The number of cover stories for Marizyme depends on current market conditions and Marizyme's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Marizyme is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Marizyme's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Marizyme Short Properties

Marizyme's future price predictability will typically decrease when Marizyme's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Marizyme often depends not only on the future outlook of the potential Marizyme's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Marizyme's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding40.5 M

Other Information on Investing in Marizyme OTC Stock

Marizyme financial ratios help investors to determine whether Marizyme OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Marizyme with respect to the benefits of owning Marizyme security.